SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)
Clinical trial NCT03552549 · TERMINATED
Trial details
- NCT number
- NCT03552549
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-05
- Primary completion
- 2001-02-19
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.